SG49702A1 - Somatotropins with alterations in the alphahelix 1 region and combinations with other mutations - Google Patents

Somatotropins with alterations in the alphahelix 1 region and combinations with other mutations

Info

Publication number
SG49702A1
SG49702A1 SG1996004237A SG1996004237A SG49702A1 SG 49702 A1 SG49702 A1 SG 49702A1 SG 1996004237 A SG1996004237 A SG 1996004237A SG 1996004237 A SG1996004237 A SG 1996004237A SG 49702 A1 SG49702 A1 SG 49702A1
Authority
SG
Singapore
Prior art keywords
somatotropins
helix
alpha
mutations
combinations
Prior art date
Application number
SG1996004237A
Other languages
English (en)
Inventor
Meir Fischer
Michael Richard Lebens
Deborah Tardy Chaleff
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of SG49702A1 publication Critical patent/SG49702A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Secondary Cells (AREA)
  • Mold Materials And Core Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
SG1996004237A 1990-11-30 1991-11-28 Somatotropins with alterations in the alphahelix 1 region and combinations with other mutations SG49702A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62165690A 1990-11-30 1990-11-30

Publications (1)

Publication Number Publication Date
SG49702A1 true SG49702A1 (en) 1998-06-15

Family

ID=24491070

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004237A SG49702A1 (en) 1990-11-30 1991-11-28 Somatotropins with alterations in the alphahelix 1 region and combinations with other mutations

Country Status (20)

Country Link
US (1) US5548068A (fi)
EP (1) EP0496973B1 (fi)
JP (1) JPH05105634A (fi)
KR (1) KR100193005B1 (fi)
AT (1) ATE163045T1 (fi)
CA (1) CA2056467C (fi)
DE (1) DE69128877T2 (fi)
DK (1) DK0496973T3 (fi)
ES (1) ES2112847T3 (fi)
FI (1) FI104489B (fi)
GR (1) GR3026761T3 (fi)
HU (1) HU215947B (fi)
IE (1) IE914153A1 (fi)
IL (1) IL100169A0 (fi)
NO (1) NO301235B1 (fi)
NZ (2) NZ260103A (fi)
PT (1) PT99648B (fi)
SG (1) SG49702A1 (fi)
TW (1) TW198040B (fi)
ZA (1) ZA919453B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006079A (en) * 1997-06-13 1999-12-21 Motorola, Inc. Radio having a fast adapting direct conversion receiver
TR200504220T2 (tr) 1998-12-17 2007-04-24 Biogen Idec Ma Inc. Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
ES2343518T3 (es) * 2002-09-09 2010-08-03 Hanall Biopharma Co., Ltd. Polipeptidos interferon alfa modificados resistentes a proteasas.
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
EP2073833A2 (en) 2006-10-20 2009-07-01 Biogen Idec MA Inc. Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
CN103458915A (zh) 2011-02-23 2013-12-18 麻省理工学院 水溶性膜蛋白及其制备和使用方法
US10373702B2 (en) 2014-03-27 2019-08-06 Massachusetts Institute Of Technology Water-soluble trans-membrane proteins and methods for the preparation and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355460B1 (en) * 1988-08-24 2000-12-27 American Cyanamid Company Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization
CA2345497A1 (en) * 1988-10-28 1990-04-28 Genentech, Inc. Growth hormone variants and method for forming growth hormone variants

Also Published As

Publication number Publication date
AU8830091A (en) 1992-06-04
ZA919453B (en) 1992-08-26
EP0496973B1 (en) 1998-02-04
NZ240718A (en) 1996-10-28
TW198040B (fi) 1993-01-11
HU215947B (hu) 1999-03-29
US5548068A (en) 1996-08-20
PT99648A (pt) 1992-10-30
ES2112847T3 (es) 1998-04-16
HUT62327A (en) 1993-04-28
FI915654A (fi) 1992-05-31
NZ260103A (en) 1996-10-28
AU662493B2 (en) 1995-09-07
NO301235B1 (no) 1997-09-29
NO914724D0 (no) 1991-11-29
ATE163045T1 (de) 1998-02-15
IL100169A0 (en) 1992-08-18
GR3026761T3 (en) 1998-07-31
FI104489B (fi) 2000-02-15
DE69128877D1 (de) 1998-03-12
KR920009413A (ko) 1992-06-25
NO914724L (no) 1992-06-01
CA2056467A1 (en) 1992-05-31
EP0496973A3 (en) 1993-02-24
IE914153A1 (en) 1992-06-03
DE69128877T2 (de) 1998-06-18
HU913723D0 (en) 1992-02-28
CA2056467C (en) 1998-07-07
KR100193005B1 (ko) 1999-06-15
PT99648B (pt) 1999-05-31
EP0496973A2 (en) 1992-08-05
FI915654A0 (fi) 1991-11-29
DK0496973T3 (da) 1998-05-04
JPH05105634A (ja) 1993-04-27

Similar Documents

Publication Publication Date Title
PL274485A1 (en) Method of obtaining stable preparations of human proteins
EP0210189A4 (en) RECOMBINANT ALVEOLAR SURFACE ACTIVE PROTEIN.
AU5258898A (en) Mutant forms of fas ligand and uses thereof
ATE404668T1 (de) Wachstumsfaktor-homologe zvegf-3
TW198040B (fi)
IL102346A0 (en) Cysteine depleted il-6 muteins
GB8727045D0 (en) Immunoglobulin e competitor
EP0315118A3 (en) Dna coding for endothelin and use thereof
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.
EP0267795A3 (en) Murine-interleukin-2 muteins
EP0723016A3 (en) Leukocyte activation factor
DK411686A (da) Peptider